RPG Investment Advisory LLC Grows Holdings in Zoetis Inc (ZTS)

RPG Investment Advisory LLC grew its position in Zoetis Inc (NYSE:ZTS) by 248.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 522 shares of the company’s stock after acquiring an additional 372 shares during the quarter. RPG Investment Advisory LLC’s holdings in Zoetis were worth $53,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Farmers & Merchants Trust Co of Chambersburg PA bought a new stake in Zoetis in the 1st quarter worth approximately $25,000. Berman Capital Advisors LLC bought a new stake in Zoetis in the 4th quarter worth approximately $26,000. Athena Capital Advisors LLC bought a new stake in Zoetis in the 4th quarter worth approximately $29,000. TCI Wealth Advisors Inc. increased its stake in Zoetis by 123.4% in the 1st quarter. TCI Wealth Advisors Inc. now owns 344 shares of the company’s stock worth $35,000 after acquiring an additional 190 shares during the last quarter. Finally, Resources Investment Advisors Inc. bought a new position in shares of Zoetis during the 4th quarter valued at approximately $31,000. 90.93% of the stock is currently owned by institutional investors and hedge funds.

In related news, insider Clinton A. Jr. Lewis sold 6,125 shares of the business’s stock in a transaction on Thursday, February 14th. The stock was sold at an average price of $91.96, for a total transaction of $563,255.00. Following the completion of the transaction, the insider now owns 45,512 shares in the company, valued at approximately $4,185,283.52. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Roxanne Lagano sold 2,000 shares of the business’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $101.89, for a total value of $203,780.00. Following the transaction, the insider now owns 30,727 shares of the company’s stock, valued at approximately $3,130,774.03. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 404,209 shares of company stock valued at $38,052,349. 0.35% of the stock is owned by company insiders.



ZTS traded down $0.41 during trading hours on Monday, reaching $101.26. 1,656,964 shares of the company’s stock traded hands, compared to its average volume of 2,322,254. Zoetis Inc has a 52-week low of $77.00 and a 52-week high of $103.33. The company has a quick ratio of 2.46, a current ratio of 3.60 and a debt-to-equity ratio of 2.95. The stock has a market cap of $48.43 billion, a P/E ratio of 32.35, a PEG ratio of 1.83 and a beta of 0.93.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Thursday, February 14th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.77 by $0.02. Zoetis had a return on equity of 73.85% and a net margin of 24.51%. The company had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the previous year, the business earned $0.69 EPS. Zoetis’s revenue was up 7.1% compared to the same quarter last year. Equities analysts anticipate that Zoetis Inc will post 3.46 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 3rd. Investors of record on Thursday, April 18th will be issued a dividend of $0.164 per share. This represents a $0.66 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date is Wednesday, April 17th. Zoetis’s payout ratio is currently 21.09%.

Several research firms have recently weighed in on ZTS. UBS Group began coverage on Zoetis in a research report on Wednesday, March 20th. They set a “neutral” rating on the stock. Stifel Nicolaus raised Zoetis from a “hold” rating to a “buy” rating and boosted their target price for the company from $97.00 to $110.00 in a research report on Monday, March 4th. Zacks Investment Research raised Zoetis from a “sell” rating to a “hold” rating in a research report on Saturday, February 16th. BMO Capital Markets boosted their target price on Zoetis from $93.00 to $101.00 and gave the company a “market perform” rating in a research report on Monday, February 25th. Finally, SunTrust Banks began coverage on Zoetis in a research report on Tuesday, March 19th. They set a “hold” rating and a $100.00 target price on the stock. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $100.57.

TRADEMARK VIOLATION WARNING: “RPG Investment Advisory LLC Grows Holdings in Zoetis Inc (ZTS)” was first reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://dakotafinancialnews.com/2019/04/16/rpg-investment-advisory-llc-grows-holdings-in-zoetis-inc-zts.html.

Zoetis Company Profile

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Read More: Why is cost of goods sold important?

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.